Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in Chronic Idiopathic Urticaria
NCT00189878Phase 2Terminated
- Sponsor
- Barnsley Hospital
- Start
- Aug 2003
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands
01
Overview
Phase 2, randomised, double-blind trial in chronic idiopathic urticaria (CIU) comparing Methotrexate with Placebo (2 arms). Primary endpoint: Positive response to treatment at 8 weeks. Started Aug 2003; status: terminated.
02
Drugs
methotrexate
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on NCT00189878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189878.